New EU Guide | Medical Device Supply Interruption

The European Commission has released a comprehensive Q&A guide to clarify new reporting obligations regarding the supply interruption or discontinuation of specific medical devices and in vitro diagnostic medical devices (IVDs). This guidance, aligned with Article 10a of the Medical Device Regulation (MDR) and the In Vitro Diagnostic Regulation (IVDR), outlines key requirements for manufacturers and economic operators to maintain patient safety and public health. Below are the highlights: 

Key Objectives of the New Requirements

• • Patient Safety & Public Health: Aims to uphold high safety standards, addressing risks associated with interrupted or discontinued device supplies. 

• • Information Obligation: Requires manufacturers to notify relevant authorities and health institutions before anticipated supply interruptions. 

• • EUDAMED Roll-Out: Facilitates a gradual implementation of the EU medical device database to enhance transparency and monitor device availability. 

Overview of the Amendment

• • Effective Date: the requirements identified in Article 10a of the MDR regarding supply interruptions or discontinuations take effect from January 10, 2025. 

• • Scope: Applies to all devices, excluding custom-made ones, where supply disruptions could impact patient safety or public health. 

Manufacturers’ Obligations

• • Notification Requirement: Manufacturers must inform economic operators, health institutions, and competent authorities at least six (6) months before an anticipated supply interruption. 

• • Unforeseen Events: If six (6) months’ notice is not possible due to unexpected circumstances, immediate notification is required. 

• • Risk Assessment: Manufacturers are required to assess and report if an interruption could lead to serious patient or public health risks. 

Economic Operators’ Responsibilities

• • Information Cascade: Economic operators must relay manufacturer notifications to downstream supply chains, health institutions, and healthcare professionals without delay. 

Specific Scenarios

Manufacturers of devices within system or procedure packs must inform relevant parties of supply disruptions. System or procedure pack producers are then obligated, per Article 10a (3), to promptly notify economic operators, health institutions, and healthcare professionals in their supply chain. 

Key Definitions

• • Interruption of Supply: A temporary device supply suspension lasting over sixty (60) days. 

• • Discontinuation of Supply: Permanent cessation of device availability. 

Information Sharing Requirements

• • Content: Notifications should outline reasons for the interruption or discontinuation, expected impacts, and any mitigation plans. 

• • Form: Information must be submitted using a standardized form, pending publication. 

For further details, consult the full Q&A guide on practical aspects of Article 10a implementation under Regulation (EU) 2024/1860 here.

_____________________________________________

If you have questions about obligations for medical device supply interruption or discontinuation, contact us so our regulatory team can assist you. 

Learn how MedEnvoy can assist you:

• • QMS Compliance Consulting
  • EU Authorized Representative
  • EU Regulatory Importer